News Focus
News Focus
icon url

Papalaka

08/09/12 9:30 AM

#3798 RE: errett #3797

If FDA was going to delay, they would have done so already.

TLON
icon url

goodwill4all

08/09/12 9:32 AM

#3799 RE: errett #3797

Agreed. The mere fact that the purpose of Marqibo is to get the patients enough time to get to transplant is a valid argument in a highly terminal patient population. The fact that 2 patients were able to successfully get to transplantation is a new milestone in this group. If the committee does not approve this, it will be a signifcant loss for the cancer community.